Sermorelin Acetate

醋酸舍莫瑞林

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSermorelin Acetate
Drug Alias Namesermorelinum丝膜来宁sermorelinaGerefGRF1-29 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGrowth hormone releasing factor agonists
TargetsGrowth hormone releasing factor
Therapy Area/IndicationsGrowth Disorders
Global Approved IndicationsGrowth Disorders
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1990/12/28
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesMerck Serono
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEmd Serono Inc
Active IndicationsN/A
Inactive IndicationsGrowth Disorders

Other Information

ATC CodeH01AC04V04CD03
Related LinksWikipediaDrugBankKEGG